Display options
Cite
Muñoz-Cano RM, Casas-Saucedo R, Valero Santiago A, et al. Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications. J Clin Med. 2019;8(9)doi: 10.3390/jcm8091338.
Muñoz-Cano, R. M., Casas-Saucedo, R., Valero Santiago, A., Bobolea, I., Ribó, P., & Mullol, J. (2019). Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications. Journal of clinical medicine, 8(9), . https://doi.org/10.3390/jcm8091338
Muñoz-Cano, Rosa M, et al. "Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications." Journal of clinical medicine vol. 8,9 (2019). doi: https://doi.org/10.3390/jcm8091338
Muñoz-Cano RM, Casas-Saucedo R, Valero Santiago A, Bobolea I, Ribó P, Mullol J. Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications. J Clin Med. 2019 Aug 29;8(9). doi: 10.3390/jcm8091338. PMID: 31470575; PMCID: PMC6780525.
Copy Download .nbib Format: NLM
Share it on

J Clin Med. 2019 Aug 29;8(9). doi: 10.3390/jcm8091338.

Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications.

Journal of clinical medicine

Rosa M Muñoz-Cano, Rocio Casas-Saucedo, Antonio Valero Santiago, Irina Bobolea, Paula Ribó, Joaquim Mullol

Affiliations

  1. Allergy Section, Pheumology & Allergy Department, Hospital Clinic, Barcelona, 08036 Catalonia, Spain. [email protected].
  2. Clinical & Experimental Respiratory Immunoallergy, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, 08036 Catalonia, Spain. [email protected].
  3. ARADyAL, Instituto de Salud Carlos III, 28029 Madrid, Spain. [email protected].
  4. Allergy Section, Pheumology & Allergy Department, Hospital Clinic, Barcelona, 08036 Catalonia, Spain.
  5. Clinical & Experimental Respiratory Immunoallergy, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, 08036 Catalonia, Spain.
  6. ARADyAL, Instituto de Salud Carlos III, 28029 Madrid, Spain.
  7. CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  8. Rhinology Unit & Smell Clinic, ENT Department, Hospital Clinic, Barcelona, 08036 Catalonia, Spain.

PMID: 31470575 PMCID: PMC6780525 DOI: 10.3390/jcm8091338

Abstract

Platelet-activating factor (PAF) is a lipid mediator involved in several allergic reactions. It is released from multiple cells of the immune system, such as eosinophils, neutrophils, and mast cells, and also exerts its effect on most of them upon specific binding to its receptor, becoming a pleiotropic mediator. PAF is considered a potential relevant mediator in allergic rhinitis, with a key role in nasal congestion and rhinorrhoea due to its effect on vascular permeability. Interestingly, despite its potential relevance as a therapeutic target, no specific PAF inhibitors have been studied in humans. However, rupatadine, a second-generation antihistamine with dual antihistamine and anti-PAF effects has shown promising results by both blocking nasal symptoms and inhibiting mast cell activation induced by PAF, in comparison to antihistamine receptor drugs. In conclusion, the inhibition of PAF may be an interesting approach in the treatment of allergic rhinitis as part of a global strategy directed at blocking as many relevant inflammatory mediators as possible.

Keywords: PAF antagonist; allergic rhinitis; anaphylaxis; asthma; epinastine; ketotifen; nasal congestion; platelet-activating factor; rupatadine

References

  1. Allergy. 2008 Apr;63 Suppl 87:5-28 - PubMed
  2. Thorax. 1993 Jun;48(6):594-8 - PubMed
  3. Postgrad Med. 2009 Jan;121(1):122-31 - PubMed
  4. Drugs. 1998 Jul;56(1):91-114 - PubMed
  5. Allergy. 1991 Aug;46(6):466-71 - PubMed
  6. Br J Pharmacol. 1993 Sep;110(1):113-8 - PubMed
  7. J Allergy Clin Immunol. 1994 Feb;93(2):526-33 - PubMed
  8. Cochrane Database Syst Rev. 2004;(1):CD001384 - PubMed
  9. Clin Rev Allergy Immunol. 2006 Feb;30(1):3-11 - PubMed
  10. J Fam Pract. 2012 Feb;61(2 Suppl):S16-22 - PubMed
  11. J Allergy Clin Immunol. 2009 Aug;124(2):307-14, 314.e1-2 - PubMed
  12. J Allergy Clin Immunol. 2009 Oct;124(4):786-92.e4 - PubMed
  13. Immunol Today. 1987;8(11):345-51 - PubMed
  14. J Biol Chem. 2014 May 30;289(22):15566-76 - PubMed
  15. J Allergy Clin Immunol. 1990 Dec;86(6 Pt 1):839-50 - PubMed
  16. J Clin Invest. 1999 Apr;103(7):989-97 - PubMed
  17. Clin Exp Allergy. 2009 May;39(5):620-2 - PubMed
  18. Int J Immunopathol Pharmacol. 2015 Dec;28(4):584-9 - PubMed
  19. J Physiol Biochem. 2004 Jun;60(2):101-11 - PubMed
  20. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):523-7 - PubMed
  21. Clin Exp Allergy. 2005 Apr;35(4):456-60 - PubMed
  22. Prostaglandins Leukot Essent Fatty Acids. 1998 Feb;58(2):99-104 - PubMed
  23. Allergol Int. 2011 Mar;60(1):69-77 - PubMed
  24. J Immunol. 1985 Sep;135(3):2033-9 - PubMed
  25. J Allergy Clin Immunol. 1991 Mar;87(3):667-73 - PubMed
  26. Pulm Pharmacol Ther. 2000;13(5):195-223 - PubMed
  27. Atherosclerosis. 2000 Jun;150(2):413-9 - PubMed
  28. Eur J Pharmacol. 1987 Dec 1;144(2):133-9 - PubMed
  29. J Allergy Clin Immunol. 2013 Jan;131(1):144-9 - PubMed
  30. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):111-8 - PubMed
  31. Sci Transl Med. 2019 Jul 10;11(500):null - PubMed
  32. J Clin Invest. 2003 Dec;112(11):1666-77 - PubMed
  33. Expert Opin Drug Saf. 2016 Oct;15(10):1439-48 - PubMed
  34. Nature. 1974 Jun 7;249(457):581-2 - PubMed
  35. Lancet. 1986 Jul 26;2(8500):189-92 - PubMed
  36. Am J Rhinol Allergy. 2013 Mar-Apr;27(2):e48-52 - PubMed
  37. Arzneimittelforschung. 1994 Mar;44(3):327-9 - PubMed
  38. J Am Acad Dermatol. 2001 Sep;45(3):387-91 - PubMed
  39. J R Coll Physicians Edinb. 2014;44(1):50-4 - PubMed
  40. Allergy. 2015 Jan;70 Suppl 100:1-24 - PubMed
  41. J Immunol. 2000 Mar 15;164(6):3360-7 - PubMed
  42. Recent Pat Inflamm Allergy Drug Discov. 2008 Jan;2(1):72-6 - PubMed
  43. J Exp Med. 1998 Jun 1;187(11):1779-88 - PubMed
  44. J Allergy Clin Immunol. 2014 May;133(5):1270-7 - PubMed
  45. N Engl J Med. 2008 Jan 3;358(1):28-35 - PubMed
  46. J Allergy Clin Immunol. 1994 Jul;94(1):109-19 - PubMed
  47. Immunopharmacol Immunotoxicol. 1992;14(1-2):207-18 - PubMed
  48. Ann Allergy Asthma Immunol. 2013 Dec;111(6):542-7 - PubMed
  49. J Investig Allergol Clin Immunol. 2017;27(3):161-168 - PubMed
  50. Int Arch Allergy Immunol. 2004 Jun;134 Suppl 1:37-43 - PubMed
  51. Blood. 2012 Mar 15;119(11):2533-44 - PubMed
  52. J Allergy Clin Immunol. 2010 Sep;126(3):466-76 - PubMed
  53. J Pharmacol Exp Ther. 1997 Jan;280(1):114-21 - PubMed
  54. Prostaglandins Leukot Essent Fatty Acids. 1997 May;56(5):373-7 - PubMed
  55. Clin Exp Allergy. 1995 Dec;25(12):1159-62 - PubMed
  56. Biochem Biophys Res Commun. 2000 May 19;271(3):812-7 - PubMed
  57. J Immunol Methods. 1993 Dec 3;166(2):251-61 - PubMed
  58. J Allergy Clin Immunol. 2014 Apr;133(4):1218-20 - PubMed
  59. J Clin Invest. 2011 Apr;121(4):1484-96 - PubMed
  60. Allergy Asthma Clin Immunol. 2014 Apr 28;10(1):20 - PubMed
  61. Fundam Clin Pharmacol. 1990;4(1):1-9 - PubMed
  62. Clin Transl Allergy. 2019 Jul 17;9:33 - PubMed
  63. J Allergy Clin Immunol. 2010 May;125(5):1137-1145.e6 - PubMed
  64. Biochem J. 1993 Jun 15;292 ( Pt 3):617-29 - PubMed
  65. Allergol Int. 2017 Apr;66(2):163-189 - PubMed
  66. Cardiovasc Drugs Ther. 2009 Feb;23(1):73-83 - PubMed
  67. Eur J Clin Pharmacol. 1992;42(3):295-9 - PubMed
  68. Allergy Asthma Clin Immunol. 2013 Nov 01;9(1):43 - PubMed
  69. J Pharmacol Exp Ther. 1998 Jan;284(1):83-8 - PubMed
  70. J Immunol. 1980 Feb;124(2):676-84 - PubMed
  71. Lipids. 1991 Dec;26(12):1172-4 - PubMed
  72. J Allergy Clin Immunol. 2004 Sep;114(3):465-74; quiz 475 - PubMed
  73. Drugs. 1990 Sep;40(3):412-48 - PubMed
  74. Rheum Dis Clin North Am. 2016 Feb;42(1):15-31, vii - PubMed
  75. Eur J Pharmacol. 1992 Jun 5;216(2):141-7 - PubMed
  76. Jpn J Pharmacol. 1990 Oct;54(2):217-26 - PubMed
  77. Int Arch Allergy Immunol. 2012;158(1):18-26 - PubMed

Publication Types